A new protocol in improving hospital care for decubitus wounds using incisional negative pressure wound therapy (Prevena™) – one-year results
摘要
The management of decubitus wounds presents significant challenges, particularly due to the complex patient population affected by prolonged immobility and comorbidities. Incisional Negative Pressure Wound Therapy (iNPWT) has emerged as a notable advancement in reducing postoperative wound complications. This study evaluates whether our proposed all-encompassing protocol, including iNPWT, combined with modified beds and early sitting without weight-bearing, enhances postoperative rehabilitation, accelerates mobilization and discharge, and improves outcomes and quality of life for patients with decubitus and other complex wounds, ultimately benefiting both patients and their caregivers.
MethodsA single-center prospective cohort study was conducted from October 2022 over one year, focusing on patients with decubitus wounds, also including other complex wound types. The intervention involved wounds treated with pedicled flaps and the application of the Prevena™ iNPWT device and a structured care protocol using specialized mattresses and early mobilization strategies.
ResultsResults from 21 patients (average age 54.62 years) over one year indicated that iNPWT substantially reduced surgical site infections (SSIs) and complications, though recurrence and dehiscence rates remained higher in decubitus wounds compared to other wounds. Decubitus patients had a median hospital stay of 26 days, and the use of iNPWT allowed for earlier patient mobilization and improved postoperative care efficiency. Staff feedback highlighted the benefits of iNPWT in simplifying wound care and enhancing patient comfort, despite some challenges in assessing wound healing progression.
ConclusionsThe study concludes that integrating iNPWT with a multidisciplinary care approach can improve postoperative outcomes and patient experiences in decubitus wound management. Further large-scale studies are needed to confirm these findings and refine care protocols.
Level of EvidenceLevel IV, therapeutic study.